MYELOMA PATIENTS EUROPE AISBL -  

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 4.966.716 225.000 1
2021 0 2.281.840 0 1
2018 0 6.097.875 115.625 1
2016 0 2.949.028 48.750 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ERASMUS UNIVERSITEIT ROTTERDAM2
ABBVIE INC1
ADELPHI VALUES1
ARTTIC1
ARTTIC INNOVATION1
ASSOCIATION INTERNATIONALE DE LA MUTUALITE ASBL1
BAYER1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CHINO1
CONSORCIO MAR PARC DE SALUT DE BARCELONA1
DRKBLUTSPENDEDIENST BADENWURTTEMBERGHESSEN GGMBH1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ESD EVALUATION SOFTWARE DEVELOPMENT1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY1
FUNDACION PUBLICA MIGUEL SERVET1
GESUNDHEIT OSTERREICH1
JOHNS HOPKINS UNIVERSITY1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KLINICKI BOLNICKI CENTAR RIJEKA1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MODUS OUTCOMES SAS1
NATIONAL CANCER CENTER1
NBETHERAPEUTICS1
NUROMEDIA1
OPTIMEDIS1
OSLO UNIVERSITETSSYKEHUS HF1
OSPEDALE SAN RAFFAELE1
PFIZER LIMITED1
QUEEN'S UNIVERSITY AT KINGSTON1
REGION HOVEDSTADEN1
SKYLINEDX BV1
STATENS LEGEMIDDELVERK1
STICHTING VUMC1
STIFTUNG FUR QUALITAT UND WIRTSCHAFTLICHKEIT IM GESUNDHEITSWESEN1
TCURX1
THE CRITICAL PATH INSTITUTE NON PROFIT CORPORATION1
THE EUROPEAN MEDICINES AGENCY1
THE UNIVERSITY OF SYDNEY1
UNIVERSIDAD DE NAVARRA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAETSKLINIKUM FREIBURG1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITEIT GENT1
UNIVERSITY HEALTH NETWORK1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF LEEDS1
UNIVERSITY OF OSLO1
UNIVERZITA KOMENSKEHO V BRATISLAVE1

Constancy:

Total number of partners: 55
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 55
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-12-01Affordability and Sustainability improvements by using new pricing, Cost-Effectiveness and ReimbursemenT models to Appraise iNnovative health technologies ASCERTAINparticipant4.966.71610
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2018-01-01SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease CARAMBAparticipant6.097.87511
2016-11-01Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients MMpredictparticipant2.949.0285